4//SEC Filing
Rutz Michael P 4
Accession 0001599220-25-000003
CIK 0001822479other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 6:08 PM ET
Size
13.5 KB
Accession
0001599220-25-000003
Insider Transaction Report
Form 4
Rutz Michael P
President of Sterigenics
Transactions
- Sale
Common Stock
2025-08-22$16.38/sh−126,611$2,074,306→ 450,204 total
Holdings
- 63,857
Stock Options
Exercise: $20.03Exp: 2032-03-02→ Common Stock (63,857 underlying) - 24,289
Performance RSUs
→ Common Stock (24,289 underlying) - 111,801
Stock Options
Exercise: $23.00Exp: 2030-11-20→ Common Stock (111,801 underlying) - 53,879
Stock Options
Exercise: $17.59Exp: 2033-03-06→ Common Stock (53,879 underlying) - 68,063
Stock Options
Exercise: $14.59Exp: 2034-03-04→ Common Stock (68,063 underlying)
Footnotes (8)
- [F1]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.30 - $16.54. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F2]These securities consist of 80,901 RSUs and 369,303 shares of Common Stock.
- [F3]No transaction is being reported on this line. Reported on a previously filed Form 4.
- [F4]These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.
- [F5]These options were granted on March 6, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in annually in three equal installments commencing March 2, 2024, subject to the Reporting Person's continued service through each such date..
- [F6]These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service thourgh each such date.
- [F7]These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.
- [F8]These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.
Documents
Issuer
Sotera Health Co
CIK 0001822479
Entity typeother
Related Parties
1- filerCIK 0001599220
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 6:08 PM ET
- Size
- 13.5 KB